Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
03 January 2023 | Story Dr Cindé Greyling | Photo Anja Aucamp
Dr Nomalungelo Ngubane
Dr Nomalungelo Ngubane, the Director: Academy for Multilingualism, is working through various initiatives to ensure that the UFS becomes and remains the South African leader in multilingualism.

The Academy for Multilingualism was established at the beginning of 2021, flowing from the UFS Language Policy (2016) that is currently under review, and which expresses the university’s commitment to multilingualism, with a particular emphasis on Sesotho, Afrikaans, and isiZulu, while English remains the primary medium of instruction for undergraduate and postgraduate studies.

The Student Language Preference Survey continues to indicate that many students have difficulty understanding English lectures due to language differences. Multilingual models from places like South America, India and South Africa were considered in order to structure the approach at the UFS.

Promoting indigenous languages

To mitigate the English barrier, the academy is developing multilingual academic glossaries. The multilingual glossaries are also intended to drive the promotion of indigenous languages (Sesotho/Afrikaans/IsiZulu) as academic languages, and to create multilingual learning spaces that embrace diverse languages.

Academic word lists from seven departments are in the process of being translated – in conjunction with the Unit of Lexicography – to create glossaries. The team at South African Sign Languages will add videos to these glossaries to provide unique and inclusive content in the realm of multilingualism. 

In 2022, the academy, in collaboration with the Library and Information Services, launched an African Languages Press with the aim of promoting and advancing publications of literature and research books using South African indigenous languages. 

The Academy for Multilingualism also promotes multilingualism through the Initiative for Creative African Narratives (iCAN), a programme that encourages students to write short stories in their indigenous home languages. By incorporating student narratives into learning material, students learn about one another, from one another.

The iCAN multilingual booklets are also used to encourage extensive reading among undergraduates and among learners in the surrounding community schools.

Use of translanguaging practices
 
The academy is also working with the Centre for Teaching and Learning’s (CTL) A_STEP programme to pilot the use of translanguaging practices in tutor sessions. UFS staff will also be trained on teaching and translanguaging practices. Voice-over translations of English lessons into Afrikaans and Sesotho in the Faculty of Theology and Religion paved the way for the academy to proceed with this practice in other subjects. The Translanguaging Seminar 2022, hosted by the academy and the CTL, was used as a platform for sharing translanguaging knowledge and practices by academics from the UFS and other institutions.

The Kovsies Multilingual Mokete has become a popular annual tradition celebrating different cultural expressions – in visual art, poetry, storytelling, drama, music, and song – by different language groups and in the different languages that are dominant at the UFS (i.e. English, Afrikaans, Sesotho, isiZulu, and Sign Language). This year’s event was held on the South Campus in October.

With its various initiatives, the Academy for Multilingualism will ensure that the UFS becomes and remains the South African leader in multilingualism.

News Archive

Nuclear Medicine on the forefront of cancer research
2017-07-10

Description: Nuclear Medicine on the forefront of cancer research Tags: Nuclear Medicine, cancer research, Dr Je’nine Horn-Lodewyk’s, tumour detection method, cancer, Department of Nuclear Medicine 

Dr Je’nine Horn-Lodewyk’s tumour detection method
could be the cost-effective breakthrough needed to decrease
the mortality rate in breast cancer patients.
Photo: Anja Aucamp

The field of Nuclear Medicine in South Africa and the rest of the world are expanding rapidly due to the development of hybrid cameras and new radiopharmaceuticals. These developments have a huge impact on the diagnosis and therapy of cancer.

The most advanced of these cameras, Positron emission tomography combined with normal CTs (PETCT), are not yet widely available in South Africa due to the cost of the cameras and the radiopharmaceuticals. A more cost-effective alternative can be of great benefit. To achieve this, the focus should be on developing new radiopharmaceuticals that can be used with the current cost-effective gamma cameras, according to University of the Free State researcher, Dr Je’nine Horn-Lodewyk from the Department of Nuclear Medicine.

Fluorodeoxyglucose (18F-FDG), a radiolabelled glucose analogue, is currently the radiopharmaceutical most commonly used in PET/CT imaging for mainly oncology indications. Although it is considered the gold standard for imaging in several malignancies, it does have certain disadvantages. An 18F-FDG PET/CT diagnostic imaging study can cost between R25 000 and R35 000 for a single patient in the private sector. The 18F-FDG is also more radioactive, which requires much stricter handling and shielding to avoid high radiation dosages to staff and patients.

Successful research potential innovative solution
In the search for the ideal radiopharmaceutical for tumour detection, the South African National Nuclear Energy Corporation (Necsa) developed a local synthesis process for ethylenedicysteine-deoxyglucose (EC-DG). EC-DG is also a glucose analogue similar to FDG. They succeeded in labelling the compound with Technetium-99-metastable-pertechnetate (99mTcO4-), the most common nuclear medicine isotope used for approximately 95% of nuclear medicine procedures, creating 99mTc-EC-DG.

In partnership with Dr Horn-Lodewyk, this compound was successfully used in various animal models and clinical scenarios, resulting in approval by the Medicine Control Council to use it in a human study. Research is also planned in order to investigate diagnostic accuracy in other cancers like lymphoma.  The end result of this research can produce a radiopharmaceutical that is cost effective, does not require the use of costly specialised equipment, has no significant side-effects, no special patient preparation, renders late imaging possible, and has decreased radiation risks.

Dr Horn-Lodewyk is grateful for the support of her mentor, Prof Anton Otto, as well as Dr Gert Engelbrecht, Head of the Department of Nuclear Medicine, Prof Jan Rijn Zeevaart from North-West University’s Preclinical Drug Development Platform and Necsa, and Judith Wagener from Necsa. This innovative research would also not have been possible without the financial assistance of Dr Glen Taylor and Eleanor van der Westhuizen in the Directorate of Research Development.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept